PracticeVideosBlogFlashcardsEspañol
All Practice Exams

Free Practice Questions for Israel Patent Attorney Exam

Exam-style questions and explanations by OpenExamPrep.

✓ No registration✓ No credit card
100+ Questions
100% Free

Loading practice questions...

Same family resources

Explore More Patent Bar & IP Agent Exams

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

Patent Bar (USPTO Registration Exam)

Practice QuestionsStudy Guide

Australian Patent Attorney Registration Exams (TTIPAB)

Practice Questions

Australian Trade Marks Attorney Registration Exams (TTIPAB)

Practice Questions

Canadian Patent Agent Knowledge Examination (CPATA)

Practice Questions

Canadian Trademark Agent Knowledge Examination (CPATA)

Practice Questions

China Patent Agent Qualification Examination (PAQE)

Practice Questions
Exam Review

Key Facts: Israel Patent Attorney Exam Exam

205 ILS

2026 Statutory Fee per Paper

Israel Patent Office fee schedule

2 Years

Mandatory Patent Internship

Patents Law 5727-1967 Section 142(a)(4)

30 Months

PCT National Phase Entry Deadline

Patents Law Section 48D with PCT Articles 22 and 39

20 Years

Standard Patent Term from Filing

Patents Law Section 52

2

Annual Examination Sittings

Israel Patent Office exam schedule

205 ILS

Fee Per Examination, Charged Separately

Israel Patent Office notice, June 2026 sitting

The Israel Patent Attorney Qualifying Examination is administered twice annually by the Israel Patent Office for a statutory fee of 205 ILS per examination paper. The examination evaluates practical patent specification and claim drafting alongside comprehensive knowledge of patent, trademark, design, copyright, and international treaty law under the Patents Law 5727-1967. This OpenExamPrep bank provides 100 independent English-language practice questions with comprehensive statutory rationales covering the complete examination scope.

Sample Israel Patent Attorney Exam Practice Questions

Try these sample questions to review concepts for the Israel Patent Attorney Exam exam. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1Under Section 3 of the Israeli Patents Law, 5727-1967 (חוק הפטנטים, תשכ"ז-1967), which cumulative statutory criteria must an invention satisfy to be eligible for the grant of a patent?
A.It must be an invention, whether a product or a process, in any field of technology, which is new, useful, possesses an inventive step, and is susceptible of industrial application.
B.It must be an aesthetic shape or ornamental pattern that has never been displayed in a retail catalog or public exhibition.
C.It must be an abstract scientific theory or mathematical formula that has received peer-reviewed academic validation.
D.It must be a commercial marketing scheme generating demonstrable financial revenue within six months of filing.
Explanation: Section 3 of the Israeli Patents Law, 1967 provides: 'An invention, whether a product or a process, in any field of technology, which is new, useful, possesses an inventive step, and is susceptible of industrial application, is a patentable invention.'
2Under Section 7(1) of the Israeli Patents Law, 1967, which of the following subject matters is explicitly excluded from patentability?
A.Medical devices used for diagnostic imaging such as magnetic resonance imaging (MRI) scanners.
B.A method of therapeutic treatment of the human body (שיטה לטיפול רפואי בגוף האדם).
C.Pharmaceutical compositions formulated into oral tablet dosage forms.
D.Novel synthetic chemical compounds possessing therapeutic antibacterial efficacy.
Explanation: Section 7(1) of the Patents Law, 1967 expressly states that notwithstanding Section 3, no patent shall be granted for 'a method of therapeutic treatment of the human body'. However, medical devices, pharmaceuticals, and synthetic compounds are patentable.
3Under Section 7(2) of the Israeli Patents Law, 1967, which biological subject matter is ineligible for patent protection?
A.Genetically engineered bacterial strains utilized in industrial chemical synthesis.
B.Recombinant DNA vectors and laboratory-isolated nucleic acid sequences.
C.New varieties of plants and animals, other than microbiological organisms not derived from nature.
D.Synthetic nutrient culture media used for in-vitro cellular propagation.
Explanation: Section 7(2) of the Patents Law excludes from patentability 'new varieties of plants or animals, except microbiological organisms not derived from nature'. Plant varieties in Israel are protected separately under the Plant Breeders' Rights Law, 1973.
4Under Section 4 of the Israeli Patents Law, 1967, what standard of publication destroys the novelty (חידוש) of an invention?
A.An oral disclosure delivered under a strict bilateral non-disclosure agreement to an institutional investor.
B.An internal research memorandum preserved solely in a locked corporate vault.
C.A confidential draft manuscript saved exclusively on an inventor's password-protected personal computer.
D.Any prior publication in Israel or abroad, in writing, by display, by use, or in any other manner, accessible to the public before the application's priority date.
Explanation: Section 4 of the Patents Law defines an invention as new if it has not been published in public, anywhere in Israel or abroad, prior to the application date (or priority date), in writing, by display, by use, or in any other manner enabling a person skilled in the art to carry it out (absolute universal novelty).
5Under Section 5 of the Israeli Patents Law, 1967, how is an 'inventive step' (התקדמות המצאתית) legally defined?
A.An advance which does not seem obvious to an average person skilled in the art (בעל מקצוע ממוצע) in light of the publications made prior to the application date.
B.Any technical innovation that required research and development expenditures exceeding 500,000 USD.
C.A modification that receives positive consumer feedback in randomized retail market surveys.
D.An invention that achieves commercial sales surpassing all pre-existing market competitors within one year.
Explanation: Section 5 of the Patents Law defines inventive step as 'an advance which does not seem obvious to an average person skilled in the art in the light of the publications made prior to the application date under section 4.'
6Under Section 10 of the Israeli Patents Law, 1967 and the Paris Convention, within what timeframe must an applicant file an Israeli patent application to claim convention priority from an earlier application filed in a convention country?
A.Within 6 months from the filing date of the foreign application.
B.Within 12 months from the filing date of the earliest foreign application.
C.Within 18 months from the foreign filing date.
D.Within 30 months from the foreign filing date.
Explanation: Under Section 10(a) of the Patents Law (implementing Article 4 of the Paris Convention), an applicant who filed a patent application in a convention state may claim priority if the Israeli application is filed within 12 months from the filing date of the earlier application.
7To successfully claim foreign priority under Section 10 of the Israeli Patents Law, 1967, what standard of correspondence must exist between the foreign priority application and the Israeli application?
A.The foreign application and Israeli application must share identical commercial brand names.
B.The foreign application must have already proceeded to final grant as an issued patent abroad.
C.The invention claimed in the Israeli application must be disclosed in an enabling manner in the foreign priority application.
D.The foreign patent office must issue a formal certificate confirming that the application is free from cited prior art.
Explanation: Section 10 requires substantive identity of disclosure: the invention claimed in the Israeli application must be fairly based on and disclosed in the foreign priority document so that a person skilled in the art could reproduce it based on that disclosure.
8In Israeli patent jurisprudence (e.g., Hughes Aircraft, Sanofi-Synthelabo), what are the legal characteristics of the hypothetical 'average person skilled in the art' (בעל מקצוע ממוצע)?
A.An exceptionally creative genius who instinctively foresees technological leaps and lateral scientific breakthroughs.
B.A patent attorney or legal scholar with deep knowledge of intellectual property law but no technical scientific training.
C.An ordinary retail consumer with no specialized scientific, mechanical, or industrial background.
D.A qualified professional in the relevant technical art who possesses common general knowledge and ordinary technical competence, but lacks creative or inventive imagination.
Explanation: Israeli courts define the 'person skilled in the art' as a fictitious legal construct: an ordinary professional in the relevant technical field equipped with normal technical skills and common general knowledge, capable of carrying out routine experimentation, but devoid of inventive imagination or creative spark.
9According to Israeli Supreme Court precedent, why must courts and examiners strictly guard against 'ex-post facto wisdom' (חכמה שלאחר מעשה / hindsight bias) when evaluating inventive step?
A.Because once an invention is disclosed, it often appears deceptively simple and obvious in retrospect, even though it was not obvious to a skilled person prior to the disclosure.
B.Because examiners are legally prohibited from citing any patent document published prior to the year 2000.
C.Because the court must apply an irrebuttable presumption that any commercially marketed product was obvious at its inception.
D.Because patent applicants are required by statute to demonstrate that they experienced psychological distress during research.
Explanation: Israeli courts consistently emphasize (e.g., in Hughes Aircraft) that evaluating inventive step must not fall prey to hindsight bias (חכמה שלאחר מעשה). Once an inventor shows the path to a solution, the solution frequently appears straightforward; the inquiry must rigorously reconstruct the state of the art as it stood before the priority date.
10Under Section 6 of the Israeli Patents Law, 1967, in which circumstance will an unauthorized prior publication of an invention NOT destroy its novelty?
A.If the inventor voluntarily published the complete specification on an open scientific blog six months prior to filing.
B.If the publication was made without the owner's consent and was derived from matter obtained from the owner, provided the patent application was filed within a reasonable time after learning of the publication.
C.If the invention was exhibited at an uncertified commercial marketing trade show without prior notification to the Registrar.
D.If the publication was made by an academic collaborator without peer-review approval.
Explanation: Section 6(1) of the Patents Law provides a non-prejudicial disclosure exception: an unauthorized publication does not destroy novelty if it is proved that the published matter was obtained from the owner of the invention and was published without their consent, provided the patent application was filed within a reasonable time after the owner learned of the publication.

About the Israel Patent Attorney Exam Exam

The Israel Patent Attorney Qualifying Examination (בחינות להסמכת עורכי פטנטים) is the statutory licensure examination administered by the Israel Patent Office under Chapter Nine of the Patents Law, 5727-1967, and Regulations 128 to 130 of the Patents Regulations 5728-1968. It grants qualifying candidates registration in the Israel Register of Patent Attorneys, conferring the exclusive statutory right to represent clients in patent application drafting, prosecution, and contentious opposition proceedings before the Registrar. Candidates must hold a university degree in a recognized technological or scientific discipline and complete a two-year internship. While the official examination consists of a practical drafting examination and an oral legal board examination, this practice bank provides an independent English-language MCQ study adaptation covering all examined statutory IP subjects.

Exam sponsor: Israel Patent Office (רשות הפטנטים, המדגמים וסימני המסחר), Ministry of Justice. The requirements and fees below concern the certification or admission exam, separate from our free practice resources.

Assessment

Written specification-drafting paper in an elective technical field (computers, electronics, mechanics, biology or chemistry) under Regulation 130; oral examination under Regulation 128 covering Israeli patent, design and trade mark law, the principles of Israeli copyright law, the substantive IP laws of industrial countries, international IP law, and the law of evidence needed for proceedings before the Registrar; and a written languages paper under Regulation 129, unless exempt under Regulations 133 or 134.

Time Limit

Set by the Patent Office for each sitting; in the June 2026 notice the Regulation 130 specification-drafting paper began at 09:00 and the Regulation 129 languages paper at 14:00

Passing Score

Determined by the Board of Examiners; no numeric pass mark is published in the Patents Regulations

Exam / Certification Fees

205 ILS per examination paper

Exam sponsor website

Fees, eligibility, and exam policies can change. Confirm them with the exam sponsor before applying or paying.

Our practice resources: topics covered

We aim to reflect publicly available exam outlines and topic information in our study resources. Coverage, format, and difficulty may differ from the actual exam, and we cannot guarantee that every detail is accurate or current. Confirm exam requirements, fees, and policies with the official exam sponsor.

30%

Israeli Patent Law & Registrability

Patentability statutory criteria under Sections 3–5 of the Patents Law (invention, novelty, inventive step, industrial application); non-patentable subject matter under Section 7 (therapeutic treatment of the human body, plant/animal varieties); priority rights under Section 10; Patent Office examination procedures (modified examination under Section 17(c), green patents, expedited examination under Section 19a); pre-grant oppositions under Section 30; patent term (20 years); and Patent Term Extensions (צווי הארכה) for pharmaceutical products under Chapter D1.

25%

Patent Specification Drafting & Claims Construction

Structural requirements of patent specifications under Regulations 20–22 (title, background, summary, drawings, detailed description); drafting independent and dependent claims; preamble, transitional phrases ('comprising' versus 'consisting of'), and body of the claim; sufficiency of description and enablement under Section 12; purposive claim construction (the Hughes Aircraft and Sanofi precedents); and the doctrine of equivalents.

15%

International IP Treaties & Cross-Border Practice

The Paris Convention for the Protection of Industrial Property (12-month priority window for patents, independence of patents); the Patent Cooperation Treaty (PCT) framework (filing with the Israel Patent Office as Receiving Office RO/IL, Chapter I international search and written opinion by ISA/IL, international publication, Chapter II demand, and national phase entry at 30 months under Section 48D with PCT Articles 22 and 39); Budapest Treaty microorganism deposits; and TRIPS Agreement principles.

15%

Trademarks, Commercial Names & Passing Off

Trade Marks Ordinance [New Version] 5732-1972 registrability standards (distinctiveness, descriptive marks, geographical indications); trademark prosecution, oppositions, and cancellations for non-use under Section 41; well-known marks (סימן מסחר מוכר היטב); Madrid Protocol international registrations designating Israel; and Commercial Torts Law 5759-1999 passing off (גניבת עין) and trade secret protections.

15%

Designs, Copyright & Patent Office Procedure

Designs Law 5777-2017 criteria (novelty, individual character, 12-month grace period, protection terms for registered and unregistered designs); Copyright Law 5768-2007 original works, moral rights, economic rights, and fair use doctrine under Section 19; contentious and ex parte proceedings before the Registrar of Patents (evidence by affidavit, cross-examination, costs, appeals to the court under Section 174); and patent attorney discipline under Sections 146 to 149.

Preparing for the Israel Patent Attorney Exam Exam

What You Need to Know

  • Passing score: Determined by the Board of Examiners; no numeric pass mark is published in the Patents Regulations
  • Assessment: Written specification-drafting paper in an elective technical field (computers, electronics, mechanics, biology or chemistry) under Regulation 130; oral examination under Regulation 128 covering Israeli patent, design and trade mark law, the principles of Israeli copyright law, the substantive IP laws of industrial countries, international IP law, and the law of evidence needed for proceedings before the Registrar; and a written languages paper under Regulation 129, unless exempt under Regulations 133 or 134.
  • Time limit: Set by the Patent Office for each sitting; in the June 2026 notice the Regulation 130 specification-drafting paper began at 09:00 and the Regulation 129 languages paper at 14:00
  • Exam / certification fees: 205 ILS per examination paper Official sources

Using Our Practice Resources

  • Work through all 100 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

Israel Patent Attorney Exam: Suggested Study Strategy

1Master the exact statutory requirements of Sections 3, 4, 5, 7, and 12 of the Israeli Patents Law, particularly prior publication standards and non-patentable therapeutic methods.
2Understand the key distinctions between Israeli claim construction doctrine (purposive construction from the Hughes Aircraft precedent) and foreign jurisdictions such as the US and EPO.
3Work through the PCT timeline, focusing on the 30-month national-phase deadline that Israel applies under PCT Articles 22 and 39 through Section 48D, and on the restoration-of-rights remedy under PCT Rule 49.6.
4Study the Designs Law 2017 thoroughly, especially the definitions of registered design versus unregistered design and the 12-month grace period for designer disclosure.
5Note that Section 73 lets the Registrar revoke a granted patent on application by any person on any ground that would have supported an opposition under Section 31, and compare that with Section 182, which makes the same grounds a defence to an infringement action in court.

Frequently Asked Questions

What qualifications are required to become a Patent Attorney in Israel?

Section 142(a) of the Patents Law 5727-1967 sets five cumulative conditions: Israeli residence; registration as an engineer under the Engineers and Architects Law or a degree from an institution of higher education in one of the Second Schedule professions (engineering, chemistry, physics, biology, pharmacy, computer science); passing the Section 143 examinations or being released from them; at least two years of internship in Israel in a patent attorney's office practising for at least three years, at the Patent Office, or in the patent department of an industrial enterprise; and payment of the prescribed fee.

What is the structure of the official Patent Attorney examination in Israel?

Three components: a written paper under Regulation 130 in which the candidate drafts a specification for an invention described to them, in an official language or in English, in an elective technical field; an oral examination under Regulation 128 covering Israeli patent, design and trade mark law, the principles of Israeli copyright law, the substantive IP laws of industrial countries, international IP law and the law of evidence needed before the Registrar; and a written languages paper under Regulation 129, unless the candidate is exempt under Regulations 133 or 134.

What is the examination fee in 2026?

205 ILS for each examination separately, paid by credit card through the Israel Patent Office online filing site. The Patent Office's June 2026 notice states this figure and sets the registration deadline at one month before each examination date.

Can lawyers (advocates) practice as patent attorneys in Israel without a science degree?

Section 154(a) gives patent attorneys the exclusive right to deal in Israel, for remuneration, with applications for patents, designs and trade marks, to prepare documents for the Registrar or a foreign industrial-property authority, and to represent parties before the Registrar. Section 154(b), however, expressly provides that this does not derogate from the right of an advocate, or of a State employee acting within their functions, to do the same acts. So an Israeli advocate may also file and prosecute patent applications, while only a registered patent attorney needs the Second Schedule scientific degree and the qualifying examinations.

Is this practice bank an official test simulation?

No. The official examination consists of a practical drafting task and an oral viva voce examination. This OpenExamPrep bank is an independent English-language MCQ study adaptation developed to test the substantive legal principles, procedural deadlines, and claim construction rules required for qualification.

What happens if a candidate fails one of the examination parts?

Regulation 131(d) provides that a person who failed an examination, in whole or in part, may apply to be examined again in it or in the part they failed. The Patents Regulations do not impose a statutory waiting period; in practice the next opportunity is the following sitting, since Regulation 124(a) fixes two sittings a year, and a fresh 205 ILS fee is payable for each examination.